Dietary Flavonoids and Colorectal Cancer: Evidence from Epidemiological Studies

Journal Title: International Archives of Clinical Pharmacology - Year 2017, Vol 3, Issue 1

Abstract

Identification of dietary agents related to colorectal carcinogenesis is of high importance to decrease the global burden of this severe disorder. As flavonoids abundantly present in plant-based food items are suggested to exert various anticancer activities in numerous experimental models, evidence from epidemiological studies about association between dietary intake of these plant secondary metabolites and the risk of colorectal cancer was compiled and is discussed in this review article. Several case-control studies have demonstrated that dietary intake of selected subclasses of flavonoids and also some individual compounds can be inversely associated with colorectal cancer risk. However, these findings are not in complete agreement and are mostly not confirmed also by the results of prospective cohort studies. Several reasons are proposed to explain discrepancies and inconsistencies of findings obtained from different works, starting from the dependence of flavonoid content on cultivation conditions of plants and methods of food processing to the factors related to study design. At that, food sources of flavonoids (tea or non-tea flavonoids) can affect the role of these polyphenolic agents on development of colorectal cancer and the potential protective effects may also depend on cancer subsites, i.e. tumors in proximal vs. distal colon or rectum. Therefore, associations between flavonoids intake and colorectal malignancies are complex and biological mechanisms and physiological importance of various established and still unknown factors certainly need more investigation. Also, further large-scale prospective cohort studies in different populations are required before any public health recommendations can be formulated for general population or at-risk individuals.

Authors and Affiliations

Keywords

Related Articles

Increase in Carbamazepine Serum Levels in Patient Treated with Voriconazole

The addition of voriconazole to chronic treatment with carbamazepine 400 mg twice a day was associated with increased carbamazepine serum levels (14.1 mg/l) and serum concentration dose ratios. Three days after the voric...

Levothyroxine for Hypothyroidism: Current Status of Biowaiver and Bioequivalence Studies

Hypothyroidism is a common disease that needs to be closely treated, in order to reduce adverse symptoms and pathophysiological effects. For thyroid hormone replacement is preferred a therapy with a synthetic form of thy...

Case Report: Addition of Naltrexone and Bupropion to Lorcaserin to Manage Olanzapine-induced Weight Gain

Antipsychotic medications, both typical and atypical, share the potential side effect of weight gain with atypical agents carrying a greater risk. Atypical antipsychotics, such as clozapine and olanzapine, which antagoni...

Insight from "Calcium Paradox" due to Ca2+/cAMP Interaction: Novel Pharmacological Strategies for the Treatment of Depression

Our discovery of "calcium paradox" phenomenon due to interaction of Ca2+/cAMP intracellular signalling pathways (Ca2+/cAMP interaction) may provide new insights for the treatment of psychiatric disorders, such as depress...

Novel Concepts for Clinical Pharmacology from "Calcium Paradox" due to Neuronal Interaction between Signalling Pathways Mediated by Ca2+ and cAMP: from 1975 to 2017

The solution for the so-called "calcium paradox" has been revealed 4 years ago, when we demonstrated the involvement of the interaction between Ca2+ and cAMP signalling pathways (Ca2+/cAMP signalling interaction) in this...

Download PDF file
  • EP ID EP349308
  • DOI 10.23937/2572-3987.1510012
  • Views 139
  • Downloads 0

How To Cite

(2017). Dietary Flavonoids and Colorectal Cancer: Evidence from Epidemiological Studies. International Archives of Clinical Pharmacology, 3(1), 1-7. https://www.europub.co.uk/articles/-A-349308